| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 126.22▼ | 126.94▼ | 126.64▼ | 124.35▲ | 112.60▲ |
| MA10 | 126.82▼ | 126.92▼ | 127.00▼ | 117.34▲ | 100.70▲ |
| MA20 | 126.93▼ | 126.71▼ | 125.90▼ | 110.25▲ | 85.43▲ |
| MA50 | 127.00▼ | 124.14▲ | 120.42▲ | 97.24▲ | 38.27▲ |
| MA100 | 127.04▼ | 119.80▲ | 113.44▲ | 80.01▲ | 25.27▲ |
| MA200 | 125.95▼ | 112.57▲ | 104.85▲ | 43.39▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.167▼ | -0.234▼ | -0.333▼ | 1.553▲ | 2.217▲ |
| RSI | 35.280▼ | 49.116▼ | 54.688▲ | 70.734▲ | 90.791▲ |
| STOCH | 4.747▼ | 41.415 | 49.743 | 85.358▲ | 83.956▲ |
| WILL %R | -92.152▼ | -80.359▼ | -60.060 | -13.745▲ | -7.464▲ |
| CCI | -148.452▼ | -86.210 | -10.311 | 123.249▲ | 177.376▲ |
|
Monday, November 17, 2025 01:37 AM
California-based TCG Crossover Management sold 1 million shares of Cidara Therapeutics, cutting its stake by approximately $49 million in the third quarter. The transaction value equaled about 2.4% of ...
|
|
Saturday, November 08, 2025 03:57 AM
Abivax delivered outstanding phase 3 results for obefazimod in ulcerative colitis, with a 16.4% placebo-adjusted clinical remission rate. See why ABVX stock is a Buy.
|
|
Wednesday, October 29, 2025 01:48 PM
) has been revised to $122.45 / share. This is an increase of 12.94% from the prior estimate of $108.42 dated September 29, 2025. The price target is an average of many targets provided by analysts.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/11/25 | 129.61 | 129.82 | 124.805 | 125.79 | 868,150 |
| 25/11/25 | 125.00 | 128.50 | 122.99 | 128.23 | 917,889 |
| 24/11/25 | 121.77 | 127.00 | 119.45 | 125.71 | 1,792,580 |
| 21/11/25 | 120.01 | 122.75 | 114.06 | 119.12 | 1,700,718 |
| 20/11/25 | 116.74 | 126.9899 | 116.35 | 122.90 | 4,466,432 |
| 19/11/25 | 113.83 | 115.39 | 111.33 | 112.95 | 797,509 |
| 18/11/25 | 112.42 | 115.425 | 110.25 | 113.83 | 1,111,750 |
| 17/11/25 | 111.96 | 116.43 | 110.56 | 113.62 | 1,517,111 |
| 14/11/25 | 103.00 | 112.50 | 103.00 | 110.39 | 2,422,963 |
| 13/11/25 | 103.17 | 105.53 | 100.50 | 100.90 | 713,827 |
|
|
||||
|
|
||||
|
|